Blue Ledge Capital
Venture capitalSeed–Growth · 1 people tracked
Find your way into Blue Ledge Capital
22 people in our graph share verified history with the Blue Ledge Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Blue Ledge Capital invests in businesses building the future, particularly focusing on advanced technology and deep science-based opportunities where others see confusion. The firm partners with institutional backing to enable a sustainable model without asset accumulation pressures, allowing for patient capital deployment alongside rigorous diligence and long-term portfolio support.
Source: firm website, verified Aug 7, 2026.
Team · 1 people
from public directories
What they invest in
from 5 of 9 portfolio companiesBiotech ×3Digital Health ×2Healthtech ×2New Materials ×2AI & Machine Learning ×1Climate Tech ×1Deep Tech ×1FoodTech ×1
HQs:United States×4
Investments · 9 tracked
founders shown can be your intro pathBy year:2023 · 12018 · 12 dated
The American Cancer Society is a nonprofit organization that provides cancer research updates, screening and prevention guidance, and community engagement opportunities.
Digital HealthHealthtechImpact & Social Good
Co-investorsBrightEdgeFred Hutchinson Cancer Research Center
Grolltex manufactures single-layer graphene and graphene-based products using patented CVD and transfer technologies, serving customers in life sciences, biotech, sensing, and electronics.
BiotechDeep TechHardwareNew MaterialsSan Diego, US
Aliaksandr Victorovich Zaretski(Founder)in
Co-investorsVertical Venture PartnersTech Coast Angels
AvantGuard develops Avantamine, an antimicrobial molecule that eliminates bacteria, viruses, and fungi on surfaces and skin without generating resistance, with an initial focus on topical treatment of the drug-resistant fungal pathogen Candida auris.
BiotechHealthtechNew Materials
Co-investorsRed Bear AngelsSOSV
Mission Barns produces cultivated meat products, primarily pork-based items like meatballs, bacon, and sausages, combining lab-grown pork fat with plant protein for consumers seeking sustainable alternatives to conventional meat.
Climate TechFoodTechBerkeley, US
Ilan Eitan Fischer(Executive Officer, Director)
BoardDavid Bowman(Director)
Co-investorsAir Street CapitalBabel VenturesBetter Ventures Central LlcBloom8Joyance PartnersLever VC+6 more
Qnovia develops a portable, pre-filled vibrating mesh nebulizer (RespiRx) that delivers nicotine via ultrasonic nebulization without combustion, paired with a cloud-connected AI platform (Neblit) providing real-time behavioral support for smoking cessation.
AI & Machine LearningBiotechDigital HealthMedical DevicesRichmond, US
Mario Danek(Founder)inBrian Quigley(Executive Officer, Director)
BoardSean Fahey(Director)Brian Riano(Director)Gregg Smith(Director)in
Co-investorsEvolution VC PartnersVice Ventures
Developer of an inhalation device and liquid formulation to deliver inhalable nicotine without harmful constituents, pursuing FDA 505(b)(2) authorization for the first inhalable Nicotine Replacement Therapy; BlueLedge led its bridge rounds ahead of its 2020/2021 Series A.
Co-investorsEvolution VC PartnersSand Hill Angels
Portfolio news
latest coverage across their companiesFrequently asked questions
- How many investments has Blue Ledge Capital made?
- Blue Ledge Capital has 7 tracked investments.
- What stage does Blue Ledge Capital invest at?
- Blue Ledge Capital invests at the Seed, Series A, Growth stages.
- What sectors does Blue Ledge Capital focus on?
- Blue Ledge Capital focuses on Biotech, Deep Tech, FoodTech, Medical Devices, New Materials.
- Does Blue Ledge Capital lead rounds?
- Yes, Blue Ledge Capital leads investment rounds.
- Who does Blue Ledge Capital co-invest with?
- Blue Ledge Capital most often shares deals with Air Street Capital, Better Ventures Central Llc, Evolution VC Partners, among 13 tracked co-investors.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Serra Ventures is an early-stage technology venture capital firm that has funded over 100 startups across the United States, with a notable focus on agtech and food tech alongside other technology sectors.
Seventure Partners is a European venture capital firm, founded in 1997 and a subsidiary of Natixis Investment Managers, investing in digital technologies and life sciences companies with strong growth potential.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.